Westlake Chemical (NYSE: WLK) reported Q4 EPS of ($4.22), $2.82 worse than the analyst estimate of ($1.40). Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.61 billion.

For earnings history and earnings-related data on Westlake Chemical (WLK) click here.